U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT07558603) titled 'Evaluate the Safety and Efficacy of AGE Serum in Post-menopausal Patients on Hormone Replacement Therapy Taking Glucagon-like Peptide-1 Agonist' on April 24.
Brief Summary: The primary objective is to assess the safety and efficacy of the AGE Serum in improving the appearance of skin in post-menopausal subjects on HRT and non-HRT who are takingGLP-1 agonist therapy through the use of investigator assessments, subject questionnaires/assessments, photography, skin imaging, and reported adverse reactions.
Study Start Date: April 20
Study Type: INTERVENTIONAL
Condition:
Laxity; Skin
Intervention:
DRUG: On GLP1 plus HRT
AGE serum is...